HOME > News > 2015

RIBOMIC, Inc. is a leading company in the world developing innovative aptamer therapeutics.

2015

 November 26, 2015 One of our scientists will present a work entitled “Development of the novel purification resin for Fc fusion proteins using RNA aptamer" at BMB2015 Biochemistry and Molecular Biology Joint Annual Meeting being held in Kobe (December 1-4, 2015).
 November 26, 2015 One of our scientists will give a talk on our R&D of Aptamer Therapeutics at the 1st Annual Meeting of Nucleic Acid Society of Japan being held in Kyoto(November 30 - December 2, 2015).
 September 7, 2015 Yoshikazu Nakamura, President and CEO, will speak at the 18th A-IMBN (Asia-Pacific International Molecular Biology Network) Annual Conference in Cheonan, Korea (September 20-22, 2015) on “Aptamer Therapeutics Targeting Pain and Fibrosis”.
 September 7, 2015 Yoshikazu Nakamura, President and CEO, will speak at the 53rd Annual Meeting of the Biophysical Society of Japan in Kanazawa, Ishikawa (September 13-15, 2015) on “Therapeutics Aptamer Discovery by RiboART System”.
 August 12, 2015 Shin Miyakawa, General Manager of Discovery Research, will give a talk on our R&D of Aptamer Therapeutics at the 23th Symposium of Drug Discovery and Pharmacology Forumn on September 17, 2015, being held at Nagai Kinen Hall, Tokyo.
 April 30, 2015 RIBOMIC Inc. is going to participate in the 14th BIOtech JAPAN 2015 of Life Science World 2015 held at Tokyo Big Sight on May 13-15, 2015. On May 14, Masatoshi Fujiwara (Ph.D.), Director of Developmental Research Laboratory of RIBOMIC Inc., will give a talk on our R&D of Aptamer Therapeutics entitled “RNA aptamer therapeutics targeting pain and lung fibrosis”.
 January 28, 2015 Yoshikazu Nakamura, President and CEO, is going to give a talk entitled “Therapeutic Aptamer Discovery by the RiboART System Targeting Lung Fibrosis” emphasizing the progress in our therapeutic development and the strong basic platform technology RiboART at the 17th TIDES International Forum, being held at San Diego, California, on May 3-6, 2015.
 January 26, 2015 Yoshikazu Nakamura, President and CEO, is going to give a talk entitled “Therapeutic Aptamer Discovery by the RiboART System Targeting Lung Fibrosis” at “Aptamers 2015” International Symposium, on March 31 and April 1, 2015, at the Oxford, United Kingdom.